NCT00224549View on ClinicalTrials.gov

PHARES Study: Management of Resistant Hypertension

PHASE4CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Hypertension
Interventions
DRUG

irbesartan, amlodipine and hydrochlorothiazide

irbesartan, amlodipine and hydrochlorothiazide

Trial Locations (1)

75015

Investigation Clinical Center European Georges Pompidou Hospital, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT00224549 - PHARES Study: Management of Resistant Hypertension | Biotech Hunter | Biotech Hunter